Prepandemic influenza vaccine (H5N1) (surface antigen, inactivated, adjuvanted) Novartis Vaccines and Diagnostics Evropska unija - slovenščina - EMA (European Medicines Agency)

prepandemic influenza vaccine (h5n1) (surface antigen, inactivated, adjuvanted) novartis vaccines and diagnostics

novartis vaccines and diagnostics s.r.l. - površinski antigeni virusa influence (hemaglutinin in nevraminidaza) seva a / viet nam / 1194/2004 (h5n1) - influenza, human; immunization; disease outbreaks - cepiva - aktivna imunizacija proti podtipu h5n1 virusa influenca a. , , this indication is based on immunogenicity data from healthy subjects from the age of 18 years onwards following administration of two doses of the vaccine containing a/vietnam/1194/2004 (h5n1)-like strain. , , prepandemic influenza vaccine (h5n1) novartis vaccines and diagnostic should be used in accordance with official recommendations.

Kvelux 300 mg filmsko obložene tablete Slovenija - slovenščina - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

kvelux 300 mg filmsko obložene tablete

lek d.d. - kvetiapin - filmsko obložena tableta - kvetiapin 300 mg / 1 tableta - kvetiapin

Kvelux 25 mg filmsko obložene tablete Slovenija - slovenščina - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

kvelux 25 mg filmsko obložene tablete

lek d.d. - kvetiapin - filmsko obložena tableta - kvetiapin 25 mg / 1 tableta - kvetiapin

Kvelux 200 mg filmsko obložene tablete Slovenija - slovenščina - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

kvelux 200 mg filmsko obložene tablete

lek d.d. - kvetiapin - filmsko obložena tableta - kvetiapin 200 mg / 1 tableta - kvetiapin